MyFinsight
Home
About
Contact
Download
Download image
Forgiveness of unrelated
vendor payables
$2,142,297
Interest income
$24,383
Total other income
(expense), net
$1,231,498
Change in fair value of
deferred underwriting...
-$756,000
Change in the fair value
of warrant...
$116,894
Interest expense,
related parties
$62,288
Net income (loss)
$113,287
Loss from operations
-$1,118,211
Total operating
expenses
$1,118,211
General and
administrative
$1,118,211
Back
Back
Income Statement
source: myfinsight.com
Liminatus Pharma, Inc. (LIMNW)
Liminatus Pharma, Inc. (LIMNW)